PTPRC and neoplasm: Global inflammation determined by CD45 staining revealed a similar number of CD45+ cells in B16F10-GCV hearts treated with anti-PD-L1 or iso Ctrl at day 50 after tumor induction (43 days after starting anti-PD-L1 or isotype Ctrl treatment) (Figures 6A,B).